NLRP3 and inflammatory bowel disease: ,42 Our data support the hypothesis that XOR inhibition might help control intestinal inflammation by reducing oxidative stress and modulating relevant inflammatory mechanisms such as NLRP3 inflammasome activation in intestinal epithelial cells, thus providing a rationale to repurpose XO inhibition as a novel mechanism to dampen intestinal inflammation in IBD.